Florida’s Hill Dermaceuticals and Hill Labs have been prohibited from introducing adulterated drugs into the interstate commerce, after a number of governmental complaints were made against them.
The order was made by the District Court for the Middle District of Florida, the US Food and Drug Administration (FDA) announced in a statement.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The government’s complaint, filed by the US Department of Justice this week, describes several deviations from current good manufacturing for drugs during the FDA’s inspections of Hill.
Hill has also been accused of, on more than one occasion, submitting false statements in support of submissions to the FDA.
FDA Associate Commissioner for Regulatory Affairs Dara Corrigan said, "Because this company continued to violate current good manufacturing practice regulations and falsify information on submissions to FDA, the agency took this action in an effort to protect consumers.
"The FDA continues to be committed to protecting consumers from potentially unsafe products that may be offered on the market," Corrigan added.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe FDA is not currently aware of any recent adverse events related to the use of any of Hill’s products.
